NASDAQ: NVAX
Novavax Inc Stock Ownership - Who owns Novavax?

Insider buying vs selling

Have Novavax Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
James Patrick KellyEVP CFO and Treasurer2026-03-075,904$9.98
$58.92kSell
Elaine OharaEVP Chief Strategy Officer2026-03-0322,429$9.49
$212.85kSell
Mark J. CaseyEVP Chief Legal Officer2026-03-0311,378$9.49
$107.98kSell
Ruxandra DraghiaakliEVP Research Development2026-03-0311,313$9.49
$107.36kSell
Ruxandra DraghiaakliEVP Research Development2026-03-0311,313$9.49
$107.36kSell
John C. JacobsPresident and CEO2026-03-0369,288$9.49
$657.54kSell
James Patrick KellyEVP CFO and Treasurer2026-03-0320,850$9.49
$197.87kSell
Elaine OharaEVP Chief Strategy Officer2026-03-0110,969$10.14
$111.23kSell
John C. JacobsPresident and CEO2026-03-0138,450$10.14
$389.88kSell
John C. JacobsPresident and CEO2026-03-0138,450$10.14
$389.88kSell

1 of 2

NVAX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NVAX insiders and whales buy or sell their stock.

NVAX Shareholders

What type of owners hold Novavax Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc9.41%15,470,365$144.80MInstitution
Shah Capital Management8.85%14,558,780$136.27MInstitution
Blackrock Inc7.85%12,901,549$120.76MInstitution
State Street Corp5.79%9,523,646$89.14MInstitution
Cadila Pharmaceuticals Ltd5.78%9,500,000$88.92MInsider
Bank Of America Corp5.04%8,290,665$77.60MInstitution
Sanofi4.18%6,880,481$64.40MInstitution
James B. 1. Tananbaum3.81%6,268,455$58.67MInsider
D E Shaw Co Inc3.64%5,992,798$56.09MInstitution
Ubs Group Ag2.98%4,894,284$45.81MInstitution

1 of 3

NVAX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NVAX71.65%17.12%Net SellingNet Selling
QURE89.72%10.28%Net SellingNet Selling
BCAX72.96%27.04%Net BuyingNet Buying
DMRA1.84%27.36%Net Selling
IMTX75.83%8.28%

Novavax Stock Ownership FAQ

Who owns Novavax?

Novavax (NASDAQ: NVAX) is owned by 71.65% institutional shareholders, 17.12% Novavax insiders, and 11.23% retail investors. Cadila Pharmaceuticals Ltd is the largest individual Novavax shareholder, owning 9.50M shares representing 5.78% of the company. Cadila Pharmaceuticals Ltd's Novavax shares are currently valued at $87.69M.

If you're new to stock investing, here's how to buy Novavax stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.